AbbVie Inc. (ABBV) vs Cisco Systems, Inc. (CSCO)
See how AbbVie Inc. and Cisco Systems, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$256.42
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page$110.49
NasdaqGS
Cisco Systems, Inc. is the world’s largest provider of networking equipment and ranks among the largest software companies globally. Its core businesses include networking hardware and software, where it holds leading market positions, as well as cybersecurity software such as firewalls. The company also offers collaboration solutions, including its Webex suite, and observability tools. Cisco primarily relies on third-party manufacturers and maintains a large sales and marketing organization of 25,000 employees across 90 countries. In total, the company employs about 80,000 people and markets its products worldwide.
View Full PageKey Metrics Comparison
AbbVie Inc.ABBV
Market Cap$453.124B
Price$256.42
24h Change+0.37%
24h Volume$4.24M
Employees57,000
Shares Outstanding1,768,169,012
Cisco Systems, Inc.CSCO
Market Cap$435.489B
Price$110.49
24h Change+0.51%
24h Volume$20.46M
Employees86,200
Shares Outstanding3,949,893,042
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ABBV
51.0%CSCO
49.0%Volume Share
Share of combined 24h volume
ABBV
17.2%CSCO
82.8%24h Performance
Price change over last 24 hours
ABBV
0.37%CSCO
0.51%Price Comparison
AbbVie Inc.
Cisco Systems, Inc.